Rheumatology, Osteoarthritis, Clinical Data Quality
8. Oct 2019
Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis: The FORWARD Randomized Clinical Trial.
ABSTRACT
Importance: Sprifermin is under investigation as a disease-modifying osteoarthritis drug.
Objective: To evaluate the effects of sprifermin on changes in total femorotibial joint cartilage thickness in the more symptomatic knee of patients with osteoarthritis.
Design, setting, and par…
Read the publication
Journal:
Authors:
- Hochberg MC,
- Guermazi A,
- Guehring H,
- Aydemir A,
- Wax S,
- Fleuranceau-Morel P,
- Bihlet AR,
- Byrjalsen I,
- Andersen JR,
- Eckstein F,